2HRA H&R GmbH & Co. KGaA

7.239USD6.600 EUR · XETRA-1.20%Mkt Cap: 269.44M USDP/E: 94.29

H&R GmbH & Co. KGaA engages in the production and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts worldwide. It operates through three segments: ChemPharm Refining, ChemPharm Sa…

Key Statistics

Company
Market Cap269.44M USD
Enterprise Value497.23M USD
Revenue (TTM)1.54B USD
Gross Profit339.73M USD
Net Income (TTM)-42.56M USD
Revenue/Share38.04 USD
Last Price7.239 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees1.7K
CountryDE
SectorBasic Materials
IndustrySpecialty Chemicals
ISINDE000A2E4T77
Valuation
P/E (Trailing)94.29
P/E (Forward)10.83
PEG127.66
EV/EBITDA2.86
EV/Revenue0.32
P/S0.18
P/B0.54
EPS (TTM)0.08 USD
EPS (Forward)0.67 USD
52W Range
4.28873% of range8.336
52W High8.336 USD
52W Low4.288 USD
Profitability
Gross Margin24.94%
Oper. Margin7.63%
EBITDA Margin11.33%
Profit Margin-3.12%
ROE-10.33%
ROA-4.24%
ROIC4.95%
ROCE4.26%
Growth
Revenue Growth32.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF101.06M USD
CapEx (TTM)65.22M USD
FCF Margin-0.54%
FCF Yield-3.11%
Net Debt177.71M USD
Net Debt/EBITDA1.02
Net Debt/FCF—
Balance Sheet
Debt/Equity0.49
Current Ratio1.71
Quick Ratio0.91
Book Value/Sh13.39 USD
Cash/Share2.29 USD
Dividends
Fwd Div Rate0.11 USD
Trail. Div Rate0.11 USD
Div. Yield0.00%
5Y Avg Yield3.25%
Payout Ratio0.00%
Ex-Div DateMay 28, 2025
Pay Date—
Splits
Last Split51:50
Split DateJul 6, 2017
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.994 USD
Upside (mean)+24.2%
Target Range8.665 USD – 9.323 USD
8.665+24.2% to mean9.323
# Analysts2
Ownership
Shares Out.37.22M
Float8.25M
Insiders78.03%
Institutions2.27%
Technical
SMA 507.719 (-6.2%)
SMA 2006.105 (+18.6%)
Beta0.29
S&P 52W Chg12.00%
Avg Vol (30d)7.83K
Avg Vol (10d)5.02K
Technical Indicators
RSI (14)41.0
MACD-0.0637
MACD Signal-0.0462
MACD Hist.-0.0175
BB Upper7.850 USD
BB Middle7.514 USD
BB Lower7.179 USD
BB Width8.93%
ATR (14)0.2604 USD
Vol Ratio (20d)0.09x

About H&R GmbH (ETR: 2HRA)

›

H&R GmbH (ETR: 2HRA) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 1,722 employees.

The shares were at 6.600 EUR on 19 November 2026, up 39.8% over 52 weeks. Its 52-week range is 3.910 EUR to 7.600 EUR: the price is 13.2% below the high and 68.8% above the low.

At a market capitalisation of 245.66M EUR, it trades at 94.3 times trailing earnings and 10.8 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a premium of 177% for 2HRA.

H&R GmbH reports return on equity of -10.3%, an operating margin of 7.6% and revenue up 32.6% year over year.

Its debt exceeds its cash by 162.03M EUR, a debt-to-equity ratio of 0.49. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 2 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 8.200 EUR is 24.2% above the current price.